发布求助
文献互助 智能选刊 最新文献

2024 年心力衰竭会议摘要更正，2024 年 5 月 11-14 日，葡萄牙里斯本。欧洲心衰杂志》。26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326

IF 16.9 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
European Journal of Heart Failure Pub Date : 2024-11-04 DOI:10.1002/ejhf.3521
{"title":"2024 年心力衰竭会议摘要更正，2024 年 5 月 11-14 日，葡萄牙里斯本。欧洲心衰杂志》。26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326","authors":"","doi":"10.1002/ejhf.3521","DOIUrl":null,"url":null,"abstract":"<p>The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.</p>\n<div>\n<div tabindex=\"0\">\n<table>\n<thead>\n<tr>\n<th>Characteristics</th>\n<th>Germany n = 47,003</th>\n<th>US n = 75,140</th>\n<th>Japan n = 9,091</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><b>Mean age (SD), years</b></td>\n<td>78.91 (10.02)</td>\n<td>74.24 (10.88)</td>\n<td>77.55 (10.02)</td>\n</tr>\n<tr>\n<td>Female n (%)</td>\n<td>23,756 (50.5)</td>\n<td>33,968 (45.2)</td>\n<td>4,084 (44.9)</td>\n</tr>\n<tr>\n<td>Male</td>\n<td>23,247 (49.5)</td>\n<td>41,132 (54.7)</td>\n<td>5,007 (55.1)</td>\n</tr>\n<tr>\n<td><b>Comorbidities n (%)</b></td>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td>Anaemia</td>\n<td>10,297 (21.9)</td>\n<td>38,313 (51.0)</td>\n<td>3,120 (34.3)</td>\n</tr>\n<tr>\n<td>Atrial fibrillation</td>\n<td>24,574 (52.3)</td>\n<td>43,768 (58.2)</td>\n<td>3571 (39.3)</td>\n</tr>\n<tr>\n<td>CKD (any stage)</td>\n<td>19,758 (42.0)</td>\n<td>44,280 (58.9)</td>\n<td>5082 (55.9)</td>\n</tr>\n<tr>\n<td>Diabetes mellitus</td>\n<td>23,059 (49.1)</td>\n<td>44,900 (59.8)</td>\n<td>3145 (34.6)</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>44,660 (95.0)</td>\n<td>73,459 (97.8)</td>\n<td>7837 (86.2)</td>\n</tr>\n<tr>\n<td>Ischaemic heart disease</td>\n<td>29,715 (63.2)</td>\n<td>59,685 (79.4)</td>\n<td>5174 (56.9)</td>\n</tr>\n<tr>\n<td>Hyperkalaemia</td>\n<td>2,195 (4.7)</td>\n<td>12,000 (16.0)</td>\n<td>1029 (11.3)</td>\n</tr>\n<tr>\n<td>Stroke</td>\n<td>4,747 (10.1)</td>\n<td>10,136 (13.5)</td>\n<td>1906 (21.0)</td>\n</tr>\n<tr>\n<td>Venous thromboembolism</td>\n<td>3,697 (7.9)</td>\n<td>5105 (6.8)</td>\n<td>1,047 (11.5)</td>\n</tr>\n<tr>\n<td>Depression</td>\n<td>13,255 (28.2)</td>\n<td>21,057 (28.0)</td>\n<td>639 (7.0)</td>\n</tr>\n<tr>\n<td>Respiratory infection</td>\n<td>13,616 (29.0)</td>\n<td>36,697 (48.8)</td>\n<td>3,711 (40.8)</td>\n</tr>\n<tr>\n<td>Hypothyroidism</td>\n<td>8,678 (18.5)</td>\n<td>20,420 (27.2)</td>\n<td>1,001 (11.0)</td>\n</tr>\n<tr>\n<td>COPD</td>\n<td>15,738 (33.5)</td>\n<td>35,363 (47.1)</td>\n<td>1711 (18.8)</td>\n</tr>\n<tr>\n<td>Myocardial infarction</td>\n<td>10,300 (21.9)</td>\n<td>30,145 (40.1)</td>\n<td>1798 (19.8)</td>\n</tr>\n<tr>\n<td>Cancer</td>\n<td>9604 (20.4)</td>\n<td>11,763 (15.7)</td>\n<td>2,091 (23.0)</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div></div>\n</div>\n<p>We apologize for this error.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"12 1","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Abstracts of the Heart Failure 2024, 11-14 May 2024, Lisbon, Portugal. European Journal of Heart Failure. 26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326\",\"authors\":\"\",\"doi\":\"10.1002/ejhf.3521\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.</p>\\n<div>\\n<div tabindex=\\\"0\\\">\\n<table>\\n<thead>\\n<tr>\\n<th>Characteristics</th>\\n<th>Germany n = 47,003</th>\\n<th>US n = 75,140</th>\\n<th>Japan n = 9,091</th>\\n</tr>\\n</thead>\\n<tbody>\\n<tr>\\n<td><b>Mean age (SD), years</b></td>\\n<td>78.91 (10.02)</td>\\n<td>74.24 (10.88)</td>\\n<td>77.55 (10.02)</td>\\n</tr>\\n<tr>\\n<td>Female n (%)</td>\\n<td>23,756 (50.5)</td>\\n<td>33,968 (45.2)</td>\\n<td>4,084 (44.9)</td>\\n</tr>\\n<tr>\\n<td>Male</td>\\n<td>23,247 (49.5)</td>\\n<td>41,132 (54.7)</td>\\n<td>5,007 (55.1)</td>\\n</tr>\\n<tr>\\n<td><b>Comorbidities n (%)</b></td>\\n<td></td>\\n<td></td>\\n<td></td>\\n</tr>\\n<tr>\\n<td>Anaemia</td>\\n<td>10,297 (21.9)</td>\\n<td>38,313 (51.0)</td>\\n<td>3,120 (34.3)</td>\\n</tr>\\n<tr>\\n<td>Atrial fibrillation</td>\\n<td>24,574 (52.3)</td>\\n<td>43,768 (58.2)</td>\\n<td>3571 (39.3)</td>\\n</tr>\\n<tr>\\n<td>CKD (any stage)</td>\\n<td>19,758 (42.0)</td>\\n<td>44,280 (58.9)</td>\\n<td>5082 (55.9)</td>\\n</tr>\\n<tr>\\n<td>Diabetes mellitus</td>\\n<td>23,059 (49.1)</td>\\n<td>44,900 (59.8)</td>\\n<td>3145 (34.6)</td>\\n</tr>\\n<tr>\\n<td>Hypertension</td>\\n<td>44,660 (95.0)</td>\\n<td>73,459 (97.8)</td>\\n<td>7837 (86.2)</td>\\n</tr>\\n<tr>\\n<td>Ischaemic heart disease</td>\\n<td>29,715 (63.2)</td>\\n<td>59,685 (79.4)</td>\\n<td>5174 (56.9)</td>\\n</tr>\\n<tr>\\n<td>Hyperkalaemia</td>\\n<td>2,195 (4.7)</td>\\n<td>12,000 (16.0)</td>\\n<td>1029 (11.3)</td>\\n</tr>\\n<tr>\\n<td>Stroke</td>\\n<td>4,747 (10.1)</td>\\n<td>10,136 (13.5)</td>\\n<td>1906 (21.0)</td>\\n</tr>\\n<tr>\\n<td>Venous thromboembolism</td>\\n<td>3,697 (7.9)</td>\\n<td>5105 (6.8)</td>\\n<td>1,047 (11.5)</td>\\n</tr>\\n<tr>\\n<td>Depression</td>\\n<td>13,255 (28.2)</td>\\n<td>21,057 (28.0)</td>\\n<td>639 (7.0)</td>\\n</tr>\\n<tr>\\n<td>Respiratory infection</td>\\n<td>13,616 (29.0)</td>\\n<td>36,697 (48.8)</td>\\n<td>3,711 (40.8)</td>\\n</tr>\\n<tr>\\n<td>Hypothyroidism</td>\\n<td>8,678 (18.5)</td>\\n<td>20,420 (27.2)</td>\\n<td>1,001 (11.0)</td>\\n</tr>\\n<tr>\\n<td>COPD</td>\\n<td>15,738 (33.5)</td>\\n<td>35,363 (47.1)</td>\\n<td>1711 (18.8)</td>\\n</tr>\\n<tr>\\n<td>Myocardial infarction</td>\\n<td>10,300 (21.9)</td>\\n<td>30,145 (40.1)</td>\\n<td>1798 (19.8)</td>\\n</tr>\\n<tr>\\n<td>Cancer</td>\\n<td>9604 (20.4)</td>\\n<td>11,763 (15.7)</td>\\n<td>2,091 (23.0)</td>\\n</tr>\\n</tbody>\\n</table>\\n</div>\\n<div></div>\\n</div>\\n<p>We apologize for this error.</p>\",\"PeriodicalId\":164,\"journal\":{\"name\":\"European Journal of Heart Failure\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":16.9000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ejhf.3521\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3521","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

A Alexander Michel 等人撰写的摘要 "心力衰竭恶化患者的住院时间、再住院率和合并症。特征德国 n = 47,003 美国 n = 75,140 日本 n = 9,091 平均年龄 (SD), 岁78.91 (10.02)74.24 (10.88)77.55 (10.02)Female n (%)23,756 (50.5)33,968 (45.2)4,084(44.9)男性23,247(49.5)41,132(54.7)5,007(55.1)合并症n(%)贫血10,297(21.9)38,313(51.0)3,120(34.3)心房颤动24,574(52.3)43,768(58.2)3571(39.3)慢性肾功能衰竭（任何阶段）19,758(42.0)44,280(58.9)5082(55.9)糖尿病23,059(49.1)44,900(59.8)3145(34.6)高血压44,660 (95.0)73,459 (97.8)7837 (86.2)缺血性心脏病29,715 (63.2)59,685 (79.4)5174 (56.9)高钾血症2,195 (4.7)12,000 (16.0)1029(11.3)中风4,747(10.1)10,136(13.5)1906(21.0)静脉血栓栓塞3,697(7.9)5105(6.8)1,047(11.5)抑郁症13,255(28.2)21,057(28.0)639(7.0)呼吸道感染13,616(29.0)36,697(48.8)3,711(40.8)甲状腺功能减退症8,678(18.5)20,420(27.2)1,001(11.0)慢性阻塞性肺病15,738(33.5)35,363(47.1)1711 (18.8)心肌梗塞10,300 (21.9)30,145 (40.1)1798 (19.8)癌症9604 (20.4)11,763 (15.7)2,091 (23.0)我们对这一错误表示歉意。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
分享
查看原文 本刊更多论文
Correction to Abstracts of the Heart Failure 2024, 11-14 May 2024, Lisbon, Portugal. European Journal of Heart Failure. 26(Suppl. 2) (2024) 246-260. https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3326

The table 1 in abstract “Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan” by A Alexander Michel, e. al. has been updated as follows.

Characteristics Germany n = 47,003 US n = 75,140 Japan n = 9,091
Mean age (SD), years 78.91 (10.02) 74.24 (10.88) 77.55 (10.02)
Female n (%) 23,756 (50.5) 33,968 (45.2) 4,084 (44.9)
Male 23,247 (49.5) 41,132 (54.7) 5,007 (55.1)
Comorbidities n (%)
Anaemia 10,297 (21.9) 38,313 (51.0) 3,120 (34.3)
Atrial fibrillation 24,574 (52.3) 43,768 (58.2) 3571 (39.3)
CKD (any stage) 19,758 (42.0) 44,280 (58.9) 5082 (55.9)
Diabetes mellitus 23,059 (49.1) 44,900 (59.8) 3145 (34.6)
Hypertension 44,660 (95.0) 73,459 (97.8) 7837 (86.2)
Ischaemic heart disease 29,715 (63.2) 59,685 (79.4) 5174 (56.9)
Hyperkalaemia 2,195 (4.7) 12,000 (16.0) 1029 (11.3)
Stroke 4,747 (10.1) 10,136 (13.5) 1906 (21.0)
Venous thromboembolism 3,697 (7.9) 5105 (6.8) 1,047 (11.5)
Depression 13,255 (28.2) 21,057 (28.0) 639 (7.0)
Respiratory infection 13,616 (29.0) 36,697 (48.8) 3,711 (40.8)
Hypothyroidism 8,678 (18.5) 20,420 (27.2) 1,001 (11.0)
COPD 15,738 (33.5) 35,363 (47.1) 1711 (18.8)
Myocardial infarction 10,300 (21.9) 30,145 (40.1) 1798 (19.8)
Cancer 9604 (20.4) 11,763 (15.7) 2,091 (23.0)

We apologize for this error.

求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍： European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信